Filter search criteria using below inputs
Click on magnifying glass icon to search
Company | Country | Symbol |
---|
Time | Volume | VTYX |
---|---|---|
09:32 ET | 8911 | 2.11 |
09:34 ET | 6183 | 2.0949 |
09:36 ET | 6835 | 2.09 |
09:38 ET | 1678 | 2.0893 |
09:39 ET | 1538 | 2.0893 |
09:41 ET | 6713 | 2.075 |
09:43 ET | 10202 | 2.0707 |
09:45 ET | 7469 | 2.0792 |
09:48 ET | 1691 | 2.075 |
09:50 ET | 950 | 2.075 |
09:52 ET | 11597 | 2.08 |
09:54 ET | 1250 | 2.075 |
09:56 ET | 5864 | 2.075 |
09:57 ET | 7885 | 2.085 |
09:59 ET | 2553 | 2.08 |
10:01 ET | 1309 | 2.08 |
10:03 ET | 3348 | 2.0801 |
10:06 ET | 2853 | 2.08 |
10:08 ET | 2321 | 2.08 |
10:10 ET | 6078 | 2.09 |
10:12 ET | 2878 | 2.1 |
10:14 ET | 2412 | 2.11 |
10:15 ET | 3098 | 2.1 |
10:17 ET | 866 | 2.09 |
10:19 ET | 1859 | 2.095 |
10:21 ET | 1489 | 2.09 |
10:24 ET | 1949 | 2.095 |
10:26 ET | 5200 | 2.0925 |
10:28 ET | 900 | 2.09 |
10:30 ET | 2996 | 2.1015 |
10:32 ET | 700 | 2.1 |
10:33 ET | 300 | 2.105 |
10:35 ET | 1360 | 2.11 |
10:37 ET | 1732 | 2.105 |
10:39 ET | 1450 | 2.1085 |
10:42 ET | 800 | 2.11 |
10:44 ET | 219 | 2.115 |
10:46 ET | 1300 | 2.115 |
10:48 ET | 341 | 2.1192 |
10:50 ET | 3017 | 2.125 |
10:51 ET | 2010 | 2.1309 |
10:53 ET | 4538 | 2.125 |
10:55 ET | 641 | 2.12 |
10:57 ET | 400 | 2.1292 |
11:00 ET | 2500 | 2.12 |
11:02 ET | 2700 | 2.12 |
11:04 ET | 3038 | 2.12 |
11:06 ET | 1398 | 2.1208 |
11:08 ET | 161 | 2.125 |
11:09 ET | 3320 | 2.115 |
11:11 ET | 702 | 2.11 |
11:13 ET | 144 | 2.11 |
11:18 ET | 700 | 2.1108 |
11:20 ET | 802 | 2.115 |
11:22 ET | 300 | 2.115 |
11:24 ET | 1014 | 2.115 |
11:26 ET | 19028 | 2.115 |
11:27 ET | 1034 | 2.115 |
11:29 ET | 1100 | 2.11 |
11:31 ET | 592 | 2.11 |
11:33 ET | 525 | 2.115 |
11:36 ET | 1349 | 2.115 |
11:38 ET | 2599 | 2.125 |
11:40 ET | 1700 | 2.125 |
11:42 ET | 2000 | 2.125 |
11:44 ET | 1011 | 2.125 |
11:45 ET | 2600 | 2.135 |
11:47 ET | 2990 | 2.12 |
11:49 ET | 952 | 2.12 |
11:51 ET | 588 | 2.105 |
11:54 ET | 100 | 2.105 |
11:56 ET | 4902 | 2.1 |
11:58 ET | 450 | 2.105 |
12:00 ET | 329 | 2.1 |
12:02 ET | 654 | 2.105 |
12:03 ET | 100 | 2.105 |
12:05 ET | 150 | 2.1092 |
12:07 ET | 100 | 2.105 |
12:09 ET | 243 | 2.1099 |
12:16 ET | 100 | 2.105 |
12:18 ET | 6868 | 2.095 |
12:20 ET | 3700 | 2.105 |
12:21 ET | 663 | 2.1 |
12:23 ET | 200 | 2.1 |
12:25 ET | 700 | 2.105 |
12:27 ET | 200 | 2.105 |
12:30 ET | 100 | 2.105 |
12:32 ET | 395 | 2.105 |
12:36 ET | 455 | 2.1092 |
12:41 ET | 435 | 2.105 |
12:43 ET | 1302 | 2.1093 |
12:45 ET | 300 | 2.105 |
12:48 ET | 700 | 2.1 |
12:50 ET | 400 | 2.105 |
12:52 ET | 1841 | 2.1 |
12:54 ET | 630 | 2.09 |
12:57 ET | 400 | 2.0989 |
12:59 ET | 2790 | 2.085 |
01:01 ET | 1984 | 2.095 |
01:03 ET | 201 | 2.09 |
01:06 ET | 214 | 2.0992 |
01:08 ET | 937 | 2.095 |
01:10 ET | 123 | 2.09 |
01:12 ET | 100 | 2.09 |
01:14 ET | 2200 | 2.0889 |
01:15 ET | 5509 | 2.09 |
01:17 ET | 2808 | 2.095 |
01:19 ET | 1000 | 2.0992 |
01:21 ET | 400 | 2.095 |
01:24 ET | 122 | 2.095 |
01:26 ET | 200 | 2.095 |
01:30 ET | 240 | 2.095 |
01:32 ET | 3549 | 2.09 |
01:33 ET | 177 | 2.095 |
01:35 ET | 118 | 2.095 |
01:39 ET | 8431 | 2.105 |
01:42 ET | 356 | 2.105 |
01:44 ET | 668 | 2.1 |
01:46 ET | 533 | 2.105 |
01:50 ET | 7031 | 2.11 |
01:51 ET | 3394 | 2.115 |
01:53 ET | 1271 | 2.11 |
01:55 ET | 478 | 2.11 |
02:02 ET | 400 | 2.115 |
02:04 ET | 471 | 2.1192 |
02:06 ET | 8503 | 2.12 |
02:08 ET | 4067 | 2.115 |
02:09 ET | 936 | 2.12 |
02:13 ET | 9607 | 2.135 |
02:15 ET | 2857 | 2.13 |
02:18 ET | 1087 | 2.13 |
02:20 ET | 19625 | 2.145 |
02:22 ET | 659 | 2.145 |
02:24 ET | 1674 | 2.145 |
02:26 ET | 2200 | 2.14 |
02:27 ET | 300 | 2.14 |
02:29 ET | 1027 | 2.14 |
02:31 ET | 7549 | 2.155 |
02:33 ET | 4156 | 2.16 |
02:36 ET | 762 | 2.16 |
02:40 ET | 100 | 2.165 |
02:42 ET | 4500 | 2.165 |
02:44 ET | 5803 | 2.17 |
02:45 ET | 2847 | 2.17 |
02:47 ET | 1709 | 2.17 |
02:49 ET | 5133 | 2.165 |
02:51 ET | 9474 | 2.155 |
02:54 ET | 900 | 2.15 |
02:56 ET | 846 | 2.16 |
02:58 ET | 114 | 2.15 |
03:00 ET | 15815 | 2.165 |
03:02 ET | 4818 | 2.17 |
03:03 ET | 6922 | 2.1755 |
03:05 ET | 15823 | 2.165 |
03:07 ET | 757 | 2.16 |
03:09 ET | 25685 | 2.155 |
03:12 ET | 6996 | 2.16 |
03:14 ET | 2365 | 2.15 |
03:16 ET | 1578 | 2.15 |
03:18 ET | 894 | 2.15 |
03:20 ET | 3016 | 2.155 |
03:21 ET | 200 | 2.15 |
03:25 ET | 5295 | 2.16 |
03:27 ET | 900 | 2.16 |
03:30 ET | 500 | 2.16 |
03:32 ET | 800 | 2.16 |
03:34 ET | 100 | 2.16 |
03:36 ET | 500 | 2.16 |
03:39 ET | 535 | 2.1543 |
03:41 ET | 344 | 2.16 |
03:43 ET | 559 | 2.155 |
03:45 ET | 1000 | 2.155 |
03:48 ET | 806 | 2.155 |
03:50 ET | 4700 | 2.155 |
03:52 ET | 9728 | 2.155 |
03:54 ET | 2335 | 2.16 |
03:56 ET | 2049 | 2.16 |
03:57 ET | 58769 | 2.12 |
03:59 ET | 170770 | 2.11 |
Company sortable | Market Cap sortable | P/E Ratio (TTM) sortable | EPS Growth (5yr) sortable |
---|---|---|---|
Ventyx Biosciences Inc | 149.1M | -0.8x | --- |
Acumen Pharmaceuticals Inc | 150.2M | -2.2x | --- |
PDS Biotechnology Corp | 151.3M | -3.4x | --- |
Immunic Inc | 143.2M | -1.1x | --- |
Context Therapeutics Inc | 141.7M | -1.8x | --- |
Inovio Pharmaceuticals Inc | 147.0M | -1.1x | --- |
Ventyx Biosciences, Inc. is a clinical-stage biopharmaceutical company. The Company is focused on developing a pipeline of small molecule product candidates to address a range of inflammatory diseases with unmet need. The Company’s pipeline includes VTX002 (S1P1R Modulator), VTX958 (TYK2 Inhibitor), and VTX2735 and VTX3232 (NLRP3 Inhibitor Portfolio). VTX002 is a sphingosine 1 phosphate receptor (S1P1R) modulator in Phase II development for patients with moderately to severely active ulcerative colitis (UC). VTX958 is an oral, selective clinical-stage inhibitor of tyrosine kinase type 2 (TYK2), an intracellular signaling kinase in the Janus kinase (JAK) family that regulates chronic inflammation in immune-mediated diseases. Its third product candidate, VTX2735, is a peripheral-targeted NOD-like receptor protein 3 (NLRP3) inflammasome inhibitor. In addition to VTX2735, it is also developing VTX3232, its lead CNS-penetrant NLRP3 inhibitor in Phase 1 development.
Our Ratings feature offers company-specific research ratings from providers such as First Call, S&P and Argus.
Open a New Account, or Login if you're a client.
You have access to a comprehensive selection of independent research reports from providers such as TD Securities, S&P, INK, and Argus.
Open a New Account, or Login if you're a client.
Market Cap | $149.1M |
---|---|
Revenue (TTM) | $0.00 |
Shares Outstanding | 70.7M |
Dividend Yield | 0.00% |
Annual Dividend Rate | --- |
Ex-Dividend Date | 01-01-01 |
Pay Date | 01-01-01 |
Beta | --- |
EPS | $-2.79 |
Book Value | $4.12 |
P/E Ratio | -0.8x |
Price/Sales (TTM) | --- |
Price/Cash Flow (TTM) | --- |
Operating Margin | --- |
Our Calendar feature allows you to view a wide selection of market and company events, including earnings, dividends, splits, rating changes, guidance, and more. Access past, current and future events in WebBroker.
Open a New Account, or Login if you're a client.